Prolonged QT dispersion in the infants of diabetic mothers
Derya Arslan1, Osman Guvenc, Derya Cimen
1Department of Pediatric Cardiology, Selcuk University Medical Faculty, 42075, Konya, Turkey, deryaamine78@hotmail.com.
Insights
Newborns of diabetic mothers with septal hypertrophy show increased QT and QTc dispersion, indicating a higher risk for arrhythmias. Early cardiac screening is crucial for these infants.
Area of Science:
- Cardiology
- Neonatology
- Pediatrics
Background:
- Maternal diabetes can lead to myocardial hypertrophy and cardiac dysfunction in newborns.
- Left ventricular hypertrophy (LVH) in these infants may impact cardiac electrical activity, specifically QT intervals.
Purpose of the Study:
- To investigate whether left ventricular hypertrophy affects QT and QTc dispersion in infants born to diabetic mothers.
- To assess the relationship between septal hypertrophy and QT variables in neonates.
Main Methods:
- Prospective cross-sectional study involving 47 neonates of diabetic mothers and 30 healthy controls.
- Electrocardiography (ECG) and echocardiography were performed.
- Newborns of diabetic mothers were categorized into groups based on septal thickness (hypertrophy vs. no hypertrophy).
Main Results:
- Infants with septal hypertrophy (n=16) exhibited significantly longer QT and QTc dispersion intervals compared to those without hypertrophy and controls (p < 0.001).
- A positive correlation was found between interventricular septal thickness at end diastole (IVSTd) and QT dispersion (r = 0.514, p = 0.042).
- Left ventricular end-systolic diameter was smaller in the septal hypertrophy group.
Conclusions:
- Elevated QT and QTc dispersion in neonates of diabetic mothers with LVH may signify an increased risk for developing cardiac arrhythmias.
- Systematic cardiac screening is recommended for these high-risk infants.
Abstract:
Myocardial hypertrophy and cardiac dysfunction frequently occur in newborns of diabetic mothers. The authors hypothesized that wall hypertrophy or disproportionate left ventricular wall thickness in newborns of diabetic mothers may affect both QT and QTc dispersion. This study aimed to assess whether left ventricular hypertrophy affects the QT variables of infants born to diabetic mothers. This prospective cross-sectional study was conducted with 47 consecutively selected neonates of gestational diabetic mothers and 30 healthy neonates born to healthy mothers. All the subjects were evaluated during the neonatal period. Electrocardiography with echocardiography was performed for the patients and the control subjects. The newborns of the diabetic mothers were classified according to septal thickness as group 1 (16 newborns with septal hypertrophy) or group 2 (31 newborns without septal hypertrophy). The study group consisted of three cohorts: groups 1, 2, and 3 (control group). Both QT and QTc dispersion were computed from a randomly selected beat as well as from an average beat derived from 12 beats included in a 10-s electrocardiography. A total of 16 infants (34%) had a septal thickness of 6 mm or greater. The left ventricular end-systolic diameter in group 1 was smaller (p = 0.0029) than in groups 2 and 3 (p = 0.003). The interventricular septal thickness at end diastole (IVSTd) and the left ventricular posterior wall thickness at end diastole in group 1 were higher than in of groups 2 and 3. The QT and QTc dispersion intervals were longer in group 1 than in groups 2 and 3 (p < 0.001), and a highly significant positive correlation was detected between IVSTd and QT dispersion (r = 0.514, p = 0.042). Elevated QT and QTc dispersions may be risk factors for the development of arrhythmias in newborns of diabetic mothers. These patients may critically need systematic cardiac screening.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Excretion
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Complications of Diabetes Mellitus


